2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE

2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE Structure
2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE structure
Common Name 2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE
CAS Number 207399-07-3 Molecular Weight 667.10500
Density N/A Boiling Point N/A
Molecular Formula C36H44ClIN2 Melting Point 232-234ºC
MSDS Chinese USA Flash Point N/A

Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.

Sci. Rep. 5 , 14713, (2015)

The effectiveness of systemic rheumatoid arthritis (RA) treatments is limited by difficulties in achieving therapeutic doses within articular joints. We evaluated the ability of intra-articular administration of injectable formulations to synergistically enha...